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Endomyocardial fibrosis (EMF), despite being the most common 
restrictive cardiomyopathy worldwide, still remains poorly under­
stood.[1,2] Although first described in Uganda,[3] this condition has 
been documented throughout the world, particularly in tropical 
and subtropical zones in Africa, Asia and South America.[1,2] Its 
aetiology remains elusive.[1,2] It possibly has different aetiologies 
in different parts of the world, with a similar final common 
path way, although this remains conjecture. Hypotheses ranging 
from infectious and allergic causes to malnutrition and toxins 
have been postulated, although none has been rigorously tested. 
The condition is associated with fibrosis of the endocardium 
(extending into the myocardium) of the right and left ventricles, 
involving predominantly the apices and inflow regions, resulting 
in impaired filling of one or both ventricles.[1,2] Patients may 
then present clinically with right, left or biventricular failure. 
Associated mitral and/or tricuspid regurgitation is common 
owing to frequent involvement of the papillary muscles with 
tethering to the ventricular wall. 
Recently, a high prevalence of predominantly asymptomatic cases 
has been described in Mozambique, suggesting that the disease may 
be underdiagnosed in neighbouring South Africa (SA).[4] We report a 
case of advanced biventricular EMF complicated by right ventricular 
outflow tract (RVOT) aneurysms, with the intention of stimulating 
clinicians to search for this condition. 
Case report
A 49­year­old woman, originally from southern Mozambique, 
presented with an 8­year history of symptoms and signs of right­
sided heart failure. She was initially misdiagnosed as having 
constrictive pericarditis. She originally presented with symptoms of 
exertional dyspnoea (grade II New York Heart Association (NYHA)), 
associated with peripheral oedema, that eventually progressed to 
anasarca. No history of rheumatic fever was reported. At the time 
of her assessment she was taking oral spironolactone 25 mg daily, 
furosemide 80 mg bid, potassium chloride 1200 mg bid, atenolol 
25 mg daily, hydrochlorothiazide 25 mg daily (added to address 
loop diuretic resistance) and warfarin according to her international 
normalised ratio (INR).
On examination, a raised jugular venous pressure was accompanied 
by anasarca (with prominent ascites). No jaundice, pallor or clubbing 
were noted. Pulse was irregular, and of variable volume consistent 
with atrial fibrillation (AF). The apex beat was undisplaced and 
normal in character. The heart sounds were normal and no signs 
of pulmonary hypertension were noted. Murmurs consistent with 
both tricuspid and mitral regurgitation were noted. The liver was 
impalpable due to the anasarca. The remainder of the examination 
was unremarkable. A urine dipstick revealed a trace of protein. 
An electrocardiogram revealed AF with a ventricular rate of 
84 beats/min, slurring of the terminal portion of the R­wave and a 
prominent R­wave in V2 (R:S ratio was 0.9). Her chest X­ray revealed 
an increased cardiothoracic ratio (0.7) with a globular heart shadow. 
This was due to left and right atrial dilation. A bulge was noted on 
the left heart border. No pleural effusions or pericardial calcification 
was present. Pulmonary venous congestion or pulmonary artery 
dilation was absent. Blood results indicated a normal full blood 
count; urea, creatinine and electrolytes; a therapeutic INR; and 
mildly deranged liver enzymes in keeping with hepatic congestion. 
She was HIV­negative.
Echocardiography revealed severely dilated atria (left atrial width 
5.1 cm and right atrial width 5.3 cm), mildly dilated left ventricle 
(LV) (LV internal diameter end diastole 5.52 cm, LV internal 
diameter end systole 3.48 cm) and a normal right ventricle (Fig. 1). 
LV wall thickness (basal) was within normal limits (interventricular 
septum end diastolic and LV posterior wall end diastolic diameters 
were 0.75 cm and 1.29 cm, respectively), although the posterior wall 
was thicker than the septum. LV ejection fraction was preserved 
(65%) but the lateral S’­velocity, on tissue Doppler imaging of the 
mitral annulus, was markedly diminished. Both ventricular apices 
were obliterated. No thrombi were noted in the atria or the apices. 
The E:E’ ratios, at both the medial and lateral mitral annulus, were 
over 10, consistent with diastolic dysfunction. Severe tricuspid 
regurgitation and moderate mitral regurgitation were noted. The 
mechanism of regurgitation was due to tethering of the leaflets owing 
to papillary muscle shortening and annular dilation, as the chordae 
and leaflets were normal, the jets were central, and there was tip­to­
tip coaptation of the leaflets of atrioventricular valves. The aortic 
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and pulmonary valves were spared. The 
estimated systolic pulmonary artery pressure 
was 37 mmHg. No features consistent with 
pericardial effusion nor constriction were 
present. In summary, these findings were in 
keeping with a restrictive cardiomyopathy, 
most likely biventricular EMF.
Cardiac catheterisation was performed. 
This revealed a mean right atrial pressure 
(RAP) of 14 mmHg. Dynamic respiratory 
manoeuvers did not influence the RAP. The 
right ventricular (RV) systolic, diastolic and 
end­diastolic pressures (RVEDPs) were 33, 
4 and 15 mmHg, respectively. The systolic, 
diastolic and mean pulmonary artery pressures 
were 37, 14 and 23 mmHg, respectively 
(normal). Mean pulmonary capillary wedge 
pressure was 20 mmHg and pulmonary 
arteriolar resistance was 58 dynes.s/cm5 
(normal). LV systolic, diastolic and end­
diastolic pressures (LVEDPs) were 110, 4 and 
14 mmHg, respectively. A dip and plateau 
sign was seen in both ventricles and LVEDP 
to RVEDP pressure difference of 1 mmHg 
was recorded. Ventricular interdependence 
was absent during deep respiration on 
simultaneous left and right ventricular 
pressure measurements. Obliteration of both 
ventricular apices and distortion of the normal 
ventricular outline was noted on right and left 
ventriculography (Figs 2 and 3). An inferior 
wall LV aneurysm was apparent in diastole. 
Two tubular aneurysms originating from 
the RVOT were noted, with dilation of the 
RVOT. These structures did not communicate 
with another chamber and emptied during 
systole. Pulmonary artery saturation was 76% 
and aortic saturation was 96%. The cardiac 
output was estimated at 4.1 L/min (cardiac 
index 2.65 L/min). The coronary arteries were 
normal. An endomyocardial biopsy was not 
performed. 
These findings were corroborated by car­
diac magnetic resonance imaging (MRI) 
(Fig. 4). Markedly dilated atria and thick­
ening of the ventricular endocardium, with 
obliteration of both apices, were noted. 
Papillary muscle thickening and shortening 
probably contributed to the tricuspid and 
mitral regurgitation. No thrombi were noted.
After a discussion with the patient, 
surgery was deferred, given the high surgical 
risk associated with the procedure. She was 
continued on the afore­mentioned medical 
therapy.
Discussion 
This case report highlights a unique example 
of biventricular EMF complicated by 
RVOT aneurysms. The classically described 
pathological changes in right­sided EMF 
include obliteration of the right ventricular 
apex by fibrosis, dilation of the RVOT, 
tricuspid regurgitation and a massively dilated 
right atrium.[5­8] In left­sided disease, partial 
LV obliteration by fibrosis occurs. Further 
extension of the process into the inflow tract 
causes papillary muscle adhesion to the LV wall 
leading to subsequent mitral regurgitation. The 
left atrium is dilated, although frequently less 
so than the right atrium. 
Interestingly, early radiological studies 
occasionally identified a convex bulge, 
high on the LV border on the chest X­ray, 
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Fig. 1.  (A) Echocardiogram (apical four chamber 
views) demonstrating massively dilated atria, 
small ventricles and obliterated right and left 
ventricular apices; (B) Calcification (arrow) 
in the left ventricular apex can be seen on the 
zoomed-in image.
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Fig. 2. A left ventriculogram showing distortion 
of the left ventricular cavity with an inferior wall 
aneurysm (arrow) and obliteration of the apex. 
(A) Diastole; (B) Systole.
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Fig. 3. A right ventriculogram demonstrating 
distortion of the right ventricular cavity with 
obliteration of the apex, dilation of the RVOT and 
two tubular aneurysms (arrows) originating from 
the RVOT (both of which empty during systole). 
(A) Diastole; (B) Systole.
Fig. 4. Cardiac MRI showing bilaterally dilated 
atria (thick arrows), small ventricles and 
obliteration of the ventricular apices (thin 
arrows). Papillary muscle thickening and 
shortening, a normal pericardium, and the 
absence of thrombi are noted.
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which was due to diastolic distention of the RVOT based on 
flouroscopy.[5,6] This feature was present in this case. The presence 
of focal, tubular aneurysms of the RVOT, however, is unique. 
These may have arisen owing to high RV diastolic pressures 
related to reduced RV volume, decreased RV compliance and 
poor RV relaxation. The RVOT is the most likely region to dilate, 
given its relatively thin wall and the absence of fibrosis in this 
region. A similar explanation may account for the LV inferior wall 
aneurysm that was observed in this case.
A recent study performed in Mozambique has contributed 
significantly to the field.[4] It not only highlighted the prevalence of 
this disease in that country but also defined a set of echocardiographic 
criteria that are useful both for diagnosis and assessment of severity. [4] 
The estimated overall prevalence of EMF was 19.8%, with the 
highest prevalence among persons 10 ­ 19 years of age (28.1%), more 
commonly in males. Biventricular EMF was most common (55.5%), 
followed by right­sided EMF (28%), and the minority, (16.5%) were 
left sided. The majority of patients were asymptomatic (77.3%), with 
most cases diagnosed only on echocardiography. Echocardiography 
is an essential tool for the diagnosis of EMF.
The proposed echocardiographic criteria for diagnosis and assess­
ment of the severity of EMF are summarised briefly.[4] A definite 
diagnosis of EMF was made in the presence of 2 major or 1 major 
and 2 minor criteria. The severity was classified as a total score, 
with <8 indicating mild disease, 8 ­ 15 moderate disease and >15 
severe disease (the maximum possible score being 35 points). The 
major and minor criteria follow with the point scores indicated in 
parentheses. The major criteria were as follows: endomyocardial 
plaques >2 mm in thickness (2); thin (≤1 mm) endomyocardial 
patches affecting more than one ventricular wall (3); obliteration of 
the RV or  LV apex (4); thrombi or spontaneous contrast without 
severe ventricular dysfunction (4); retraction of the RV apex (RV 
apical notch) (4); and atrioventricular valve dysfunction due to 
adhesion of the valvular apparatus to the ventricular wall (1 ­ 4, 
depending on the severity of regurgitation). The minor criteria were 
as follows: thin endomyocardial patches localised to one ventricular 
wall (1); restrictive flow pattern across mitral or tricuspid valves 
(2); pulmonary valve diastolic opening (2); diffuse thickening of the 
anterior mitral leaflet (1); enlarged atrium with normal­size ventricle 
(2); m­mode movement of the interventricular septum and flat 
posterior wall (1); and enhanced density of the moderator or other 
intraventricular bands (1). Based on this scoring system, our patient 
had a score of least 14, indicating moderate disease.
The differential diagnosis includes dilated cardiomyopathy, 
constrictive pericarditis, tuberculous pericarditis and rheumatic heart 
disease.[1,2] These conditions have a high prevalence in the areas where 
EMF is endemic, although a careful clinical and echocardiographic 
review will usually yield the diagnosis. Ebstein’s anomaly may mimic 
right­sided EMF. Furthermore, other restrictive cardiomyopathies 
such as amyloidosis, haemochromatosis and sarcoidosis may pose 
a diagnostic dilemma. Cardiac MRI would be useful in this regard 
if the diagnosis remains in doubt. Cardiac malignancies constitute 
another possible diagnostic group. The treatment has been reviewed 
elsewhere in detail and will not be discussed.[1]
Conclusion
This case report highlights the importance of considering the 
diagnosis of EMF, in particular in patients originally from endemic 
areas. Although EMF is not endemic in SA, SA has a large migrant 
population from countries where the disease is endemic, in particular 
Mozambique. For this reason, persistent vigilance is necessary to 
diagnose and correctly manage this fascinating disease.
1. Mocumbi A, Yacoub S, Yacoub M. Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: 
Myocardial disease. Heart 2008;94(3):384­390. DOI:10.1136/hrt.2007.136101
2. Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: Still a mystery after 60 years. PLoS Negl Trop 
Dis 2008;2(2):e97. DOI:10.1371/journal.pntd.0000097
3. Davies J. Endomyocardial fibrosis in Uganda. East Afr Med J 1948;25:10­16.
4. Mocumbi A, Ferreira M, Sidi D, Yacoub M. A population study of endomyocardial fibrosis in a rural 
area of Mozambique. N Engl J Med 2008;359(1):43­49. DOI:10.1056/NEJMoa0708629
5. Cockshott W, Ŝarić S, Ikeme A. Radiological findings in endomyocardial fibrosis. Circ 1967;35(5):913­
922. DOI:10.1161/01.CIR.35.5.913
6. Cockshott W. Angiocardiography of endomyocardial fibrosis. Br J Radiol 1965;38:192­200.
7. Connor D, Somers K, Hutt M, Manion W, D’Arbela P. Endomyocardial fibrosis in Uganda (Davies’ 
disease). Part I. An epidemiologic, clinical, and pathologic study. Am Heart J 1967;74:687­709.
8. Connor D, Somers K, Hutt M, Manion W, D’Arbela P. Endomyocardial fibrosis in Uganda (Davies’ 
disease). Part II. An epidemiological, clinical, and pathological study. Am Heart J 1968;74:107­124.
Accepted 7 March 2016.
